For informational and research purposes only.
Research, explained. Explore peptides, supplements, hormone health, longevity and red light therapy with clear, practical breakdowns of what the studies actually tell us.
Metabolism, recovery and emerging research
Sharing the GHRH receptor pathway does not make sermorelin and tesamorelin interchangeable. Their research populations, outcomes, and approved uses differ.
Read articleMecasermin and LR3 share a biological family, but their molecules, clinical uses and supporting evidence are different.
Read articleThe early comparison tested different insulin schedules. Later studies and current guidance explain why its thirteen completers cannot settle every cat's choice.
Read articleKisspeptin-54 changed sexual brain responses in short trials. Here is what imaging, tumescence and questionnaire results mean for daily treatment.
Read articleGonadorelin and hCG enter the reproductive hormone pathway at different points. Learn why similar hormone goals do not establish clinical interchangeability.
Read articleCompare the treatment questions behind PT-141 and sildenafil, from receptor mechanisms to male laboratory studies, combination evidence and safety.
Read articleHuman LL-37 wound studies have mixed results. Understand the larger trial’s overall finding, its exploratory size subgroup and the difference between granulation and closure.
Read articleMelanotan I and II share a research history, but their molecules, human studies and finished products are different. Learn which conclusions cannot be transferred.
Read articleMOTS-c blood measurements are scientifically interesting, but assay differences and missing clinical thresholds limit what an individual result can tell you.
Read articleWhat small GHK-Cu trials measured in wrinkles, laser recovery, ulcers, and eyebrows—and where cosmetic claims exceed those findings.
Read articleDAC changes the molecule and its exposure. Learn which CJC-1295 form was studied and why no-DAC labels cannot inherit its clinical results.
Read articleADHD claims need studies of the diagnosis and its daily effects. Semax mechanisms, small healthy-volunteer experiments and older report citations do not settle that question.
Read article85–96 of 323 articles
